Electrome
PrivateCompany Overview
Electrome is a therapeutic devices company that has developed a bioelectric therapy platform designed to modulate cellular behavior using electrical signals. The company's platform integrates artificial intelligence-driven modeling, digital twin simulations, and scalable hardware systems for non-invasive treatment delivery for pain, inflammation, infection, and cancer.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Patient Engagement
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Electrome Comparables
Compare Electrome with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BioElectronics Corporation | 78% | |
| Regenesis Biomedical, Inc. | 77% | |
| electroCore | 77% | |
Electrome Funding Rounds
Historical fundraising activity
Electrome Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Electrome's valuation, stock price, and market status.